SOLEUS CAPITAL MANAGEMENT, L.P. other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}
{{ Info.Homepage }}

Adviser Profile

As of Date:

07/03/2024

Adviser Type:

- Large advisory firm

Number of Employees:

17 13.33%

of those in investment advisory functions:

9 12.50%

Registration:

SEC, Approved, 6/25/2020

Other registrations (2)
Former registrations

SOLEUS CAPITAL MANAGEMENT, L.P.

AUM:

1,979,290,655 34.52%

of that, discretionary:

1,979,290,655 34.52%

Private Fund GAV:

1,979,290,655 34.52%

Avg Account Size:

247,411,332 51.33%

SMA’s:

NO

Private Funds:

6 1

Contact Info

475 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
1B 1B 1B 841M 631M 420M 210M
2020 2021 2022 2023

Recent News

Hedge Fund and Insider Trading News: Jeffrey Ubben, Nelson Peltz, John Paulson, Bill Ackman, Ray Dalio, Soleus Capital Management, Citi Trends Inc. (CTRN), Alta Equipment Group Inc (ALTG), and More
11/30/2023

Activist Investor Ubben Shutting Down Inclusive Capital – Sources (Reuters) Bill Ackman Says Biden Past His ‘Peak,’ Urges Him To Drop Out Of 2024 Race (New York Post) Billionaire John Paulson’s New Headache: Porsche Dealership Catches Fire (The Daily Beast) Citadel and Its Peers Are Piling Into the Same Trades. Regulators Are Taking Notice (Bloomberg) […]

Insider Monkey

Hedge Fund and Insider Trading News: Daniel Loeb, Ken Griffin, Bill Ackman, Jim Simons, Soleus Capital Management, Archegos Capital Management, RenaissanceRe Holdings Ltd. (RNR), and More
08/15/2022

Bill Ackman’s Greatest Trade (Data Driven Investor) How a hedge fund manager turn 27 million into 2.6 billion dollars within 30 days. From 2015 to 2018, hedge fund manager Bill Ackman had negative returns while the S&P 500 returns were positive. The investors started withdrawing their investment from his hedge fund because of his lousy […]

Insider Monkey

Soleus Is Launching a New PE Fund | Institutional Investor
08/15/2022

A low-profile but very successful healthcare hedge fund is raising money for a new private equity fund.The firm, Soleus Capital Management, ...

institutionalinvestor.com

Soleus Capital Management, L.P. Buys DICE Therapeutics Inc, United Therapeutics Corp, Flexion ...
11/15/2021

Related Stocks: LNTH, CDNA, SRDX, SIEN, EPIX, NPCE, DICE, UTHR, FLXN, ENTA, ORGO, NRIX, MDXG, RVMD, TKNO, GLTO, PODD, DXCM,

gurufocus.com

Soleus Capital Management, L.P. Buys BioAtla Inc, NeuroPace Inc, C4 Therapeutics Inc, Sells ...
08/23/2021

Related Stocks: EDAP, NVCR, NEO, SIEN, SRDX, ITMR, BCAB, NPCE, CCCC, CRSP, SKIN, CVRX, VSPR, FLXN, EXEL, ALXN, PHG, DRIO,

gurufocus.com

Vericel Corp.
04/03/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons


Private Funds Structure

Fund Type Count GAV
Hedge Fund 2 $1,569,617,013
Private Equity Fund 4 $409,673,642

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM # funds
COURAGE CAPITAL MANAGEMENT, LLC 144.3m - 976.9m - - - - 1.1b 1.1b 6
B. RILEY CAPITAL MANAGEMENT 61.5m - 138.9m - - - - 200.4m 200.4m 4
GENERATIVE INVESTMENT PARTNERS LP 43.8m - 86.7m - - - - 130.5m 124.8m 6
TYRUS CAPITAL S.A.M. 301.7m - 591.1m - - - - 892.8m - 5
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 1.4b - 629.9m - - - - 2.0b - 6
MHR FUND MANAGEMENT LLC 561.3m - 4.8b - - - - 5.3b 5.3b 10
HIRTLE, CALLAGHAN & CO., LLC 67.6m - 153.3m - - - - 220.9m 19.2b 11
ASIA DEBT MANAGEMENT HONG KONG LIMITED 599.5m - 436.4m - - - - 1.0b - 10
400 CAPITAL MANAGEMENT LLC 5.2b - 3.4b - - - - 8.6b 7.1b 18
BTG PACTUAL ASSET MANAGEMENT US , LLC 18.4b - 2.1b - - - 18.8m 20.5b 27.8b 24

Private Funds



Employees




Brochure Summary

Overview

Soleus Capital is an investment adviser with its principal place of business located in Greenwich, CT. Soleus Capital was formed in 2017 and began operations in 2018. The Adviser is privately held by its general partner, Soleus GP, LLC, which is controlled by Guy B. Levy. Soleus Capital provides investment advisory services to privately offered pooled investment funds (“Funds”) and may, in the future, provide advisory services to managed accounts (collectively with the Funds, the “Clients”). Soleus Capital manages each Client’s assets on a fully discretionary basis in accordance with the investment objectives outlined in the relevant Offering Documents (defined below) and/or investment management agreement for each Client. Soleus Capital manages each Client’s portfolio in accordance with a fundamentals-driven strategy. Soleus Capital’s primary investment strategy seeks superior risk-adjusted returns over time by investing in the healthcare sector (including biotechnology, medical technology, life science tools, healthcare services and other related subsectors). Soleus Capital currently manages hedge funds, private equity funds, and special purpose vehicles. Soleus Capital also anticipates possibly managing one or more credit strategies in the future, including a strategy that would seek to invest principally in loans, asset-backed securities, convertible bonds, preferred equity, and other debt and debt-related instruments, primarily issued by small- and mid-cap publicly traded companies and privately held growth-stage companies in the healthcare sector. The hedge funds generally employ a long/short strategy and primarily invest in equity securities of U.S. and non-U.S. publicly traded healthcare companies. The private equity funds
generally seek to invest in middle-to-late stage investments in anticipation of a potential near-term initial public offering, private investments in public equities, and other investible, illiquid securities, including convertible equity and debt securities. With respect to the Funds, Soleus Capital manages each Fund in accordance with the relevant limited partnership agreement, investment management agreement, offering memorandum , or other applicable Fund documentation (collectively, “Offering Documents”), where applicable. Any Fund restrictions on investments are set forth in each respective Fund’s Offering Documents. Soleus Capital does not tailor its investment advice to the individual investors in each Fund that it manages. As such, investors cannot impose restrictions on the types of investments made through the Funds. Subject to applicable law and each Fund’s Offering Documents, the general partners of the Funds have entered into side letter arrangements with certain investors and may continue to do so in the future. Certain side letters have the effect of altering or supplementing the terms of such investors’ investments in a Fund, including reductions of fees. In the future, side letters could provide certain investors additional access to portfolio information or rights to make withdrawals. To the extent such side letter arrangements exist, certain investors in a Fund will receive more favorable fees, access to information, liquidity, or other terms. Soleus Capital does not participate in any wrap fee programs. As of December 31, 2023, Soleus Capital managed approximately $1,979,290,655 of Client assets on a discretionary basis. Soleus does not manage any Client assets on a non-discretionary basis.